Skip to content
Back to Investors
S

SynBioVen

Venture Capital

Portfolio

2

companies

Investment by month

By category

  • AI/ML£7.9M

By location

  • London£5.0M
  • Norwich£2.9M

Portfolio companies

HotHouse Therapeutics

HotHouse Therapeutics

HotHouse Therapeutics develops sustainable pharmaceutical compounds using an AI-optimised plant-based chemistry platform.

SM

Solena Materials

Solena Materials develops biodegradable protein fibres using artificial intelligence and synthetic biology.


Recent investments

Pre-Seed
£2.9M

The Norwich-based drug discovery startup emerged from stealth with backing from SynBioVen, Start Codon, UKI2S, Twin Path Ventures, Wren Capital, angels, and Innovate UK.

"We grow greener medicines using a platform that makes the impossible accessible. The drug discovery field desperately needs new chemical space and the vaccine field needs new adjuvants, with supply chains that work for everyone. By combining AI with plant engineering, we can reach molecules others cannot, and scale them in a way that supports global health, not just high-income markets."
— David Sheppard, CEO
Seed
$6.7M

The seed round was led by Sir David Harding and will fund a relocation to a new facility at Imperial's White City Deep Tech Campus.

"We’re creating protein sequences that don’t exist in nature to have the performance specifications we need while also being highly manufacturable"
— James MacDonald, CEO and technical lead